ARTICLE | Clinical News
SLx-2101: Phase I started
June 13, 2005 7:00 AM UTC
Surface Logix started a double-blind, Phase I trial of SLx-2101 to treat endothelial dysfunction and erectile dysfunction (ED) in 40 healthy male subjects. ...
Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
Surface Logix started a double-blind, Phase I trial of SLx-2101 to treat endothelial dysfunction and erectile dysfunction (ED) in 40 healthy male subjects. ...